Neurometabolic disorder due to serine deficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:35705
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Neurometabolic disorder due to serine deficiency is a rare inherited condition where the body cannot make enough of an amino acid called serine. Serine is a building block that the brain and nervous system need to develop and work properly. Without enough serine, the brain is unable to form certain fats (called sphingolipids) that are essential for healthy nerve cells. This disease is also sometimes called serine biosynthesis defect or, depending on the specific gene involved, conditions like 3-phosphoglycerate dehydrogenase (3-PGDH) deficiency, phosphoserine aminotransferase (PSAT) deficiency, or phosphoserine phosphatase (PSP) deficiency. The condition mainly affects the brain and nervous system. Babies and children with this disorder often have a very small head (microcephaly), severe intellectual disability, and seizures that are hard to control. Some children also have problems with movement and muscle tone. Because serine is needed throughout brain development, symptoms often appear early in life and can be quite serious if not treated. The good news is that treatment exists. Giving serine (and sometimes glycine) as a supplement can help replace what the body cannot make on its own. When treatment is started early — ideally before or shortly after birth — it can significantly reduce seizures and improve brain development. However, treatment started later in life may have more limited benefits. Regular monitoring by a team of specialists is important to manage symptoms and adjust treatment over time.

Also known as:

Key symptoms:

Very small head size (microcephaly)Severe intellectual disability or developmental delaySeizures, often starting in infancyLow muscle tone (floppiness) or abnormal muscle stiffnessDelayed or absent speech and language developmentDifficulty walking or problems with coordinationFeeding difficulties in infancyIrritability or abnormal behaviorPoor growthAbnormal eye movements or vision problems in some cases

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Feb 2026GLYCOPYRROLATE: New indication approved
FDAcompleted
Sep 2025GLYCOPYRROLATE: New indication approved
FDAcompleted
Jul 2025GLYCOPYRROLATE: New indication approved
FDAcompleted
Jul 2024GLYCOPYRROLATE: New indication approved
FDAcompleted
Jul 2018GLYCOPYRROLATE: New indication approved
FDAcompleted
Mar 2014

GLYCOPYRROLATE: New indication approved

FDAcompleted
Jul 2010

Cuvposa: FDA approved

To reduce chronic drooling in patients aged 3 - 16 with neurologic conditions associated with problem drooling (e.g. cerebral palsy)

FDAcompleted
May 2005GLYCOPYRROLATE: New indication approved
FDAcompleted
Nov 2004GLYCOPYRROLATE: New indication approved
FDAcompleted
Jun 2003GLYCOPYRROLATE: New indication approved
FDAcompleted

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Neurometabolic disorder due to serine deficiency.

View clinical trials →

No actively recruiting trials found for Neurometabolic disorder due to serine deficiency at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Neurometabolic disorder due to serine deficiency community →

Specialists

1 foundView all specialists →
EG
Eleonora Gambineri
Bologna
Specialist

Rare Disease Specialist

16 Neurometabolic disorder due to serine deficiency publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Neurometabolic disorder due to serine deficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Neurometabolic disorder due to serine deficiencyForum →

No community posts yet. Be the first to share your experience with Neurometabolic disorder due to serine deficiency.

Start the conversation →

Latest news about Neurometabolic disorder due to serine deficiency

Disease timeline:

New trial: Immunodeficiency and Cancer: Identification of Congenital Immune System Defects Underlying Paediatri

Phase NA trial recruiting. Analysis of biological sample and clinical data

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the best dose of serine and glycine for my child, and how often should it be given?,How will we know if the treatment is working, and what tests will be done to check?,Should other family members be tested for this condition, including future pregnancies?,Is prenatal treatment an option if we have another pregnancy?,What therapies (physical, speech, occupational) should my child start, and how soon?,Are there any clinical trials or research studies we could join?,What signs should prompt me to seek emergency care, and what should I tell emergency doctors about this condition?

Common questions about Neurometabolic disorder due to serine deficiency

What is Neurometabolic disorder due to serine deficiency?

Neurometabolic disorder due to serine deficiency is a rare inherited condition where the body cannot make enough of an amino acid called serine. Serine is a building block that the brain and nervous system need to develop and work properly. Without enough serine, the brain is unable to form certain fats (called sphingolipids) that are essential for healthy nerve cells. This disease is also sometimes called serine biosynthesis defect or, depending on the specific gene involved, conditions like 3-phosphoglycerate dehydrogenase (3-PGDH) deficiency, phosphoserine aminotransferase (PSAT) deficiency

How is Neurometabolic disorder due to serine deficiency inherited?

Neurometabolic disorder due to serine deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Neurometabolic disorder due to serine deficiency typically begin?

Typical onset of Neurometabolic disorder due to serine deficiency is infantile. Age of onset can vary across affected individuals.

Which specialists treat Neurometabolic disorder due to serine deficiency?

1 specialists and care centers treating Neurometabolic disorder due to serine deficiency are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.